Logo image
Back
Sinonasal Mucosal Melanoma: A Population-based Comparison of the EUROCARE and SEER Registries
Journal article   Open access   Peer reviewed

Sinonasal Mucosal Melanoma: A Population-based Comparison of the EUROCARE and SEER Registries

David Temmermand, Suat Kilic, Mina Mikhael, Jennifer Butler, Aykut A. Unsal and EUROCARE 5 Working Grp
International Archives of Otorhinolaryngology, v 26(3), pp e446-e452
01 Jul 2022
DOI: https://doi.org/10.1055/s-0041-1740099
PMID: 35846812
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1055/s-0041-1740099View
Published, Version of Record (VoR) Open

Abstract

Original Research
Abstract Introduction  Sinonasal melanomas are rare tumors with no comparative survival studies between Europe and the US. Objective  To provide a population-based survival analysis between the two continents. Methods  The European Cancer Registry (EUROCARE) and the United States Surveillance, Epidemiology, and End Results (SEER) databases were queried to identify patients diagnosed with sinonasal melanoma between 2000 and 2007. Relative survival (RS) data were grouped by age, gender, geographic region, extent of disease, and treatment modality. Results  A total of 1,294 cases were identified between 2000 and 2007 (935 from EUROCARE-5 and 359 from SEER). Females were most commonly identified in Europe (56.4%) and in the US (54.9%). Patients over the age of 65 years comprised the greatest proportion of patients in Europe (70%) and in the US (71%). By region, Southern Europe had the highest 5-year RS (31.6%, 95% confidence interval [CI] = [21.3–42.5%]), and Eastern Europe the lowest (16.5%, [7.5–28.5%]). The aggregate European 5-year RS was 25.4% [21.8–29.1%] and the U.S. was (29.7%, [23.6–36%]). Conclusions  Although increasing in incidence, sinonasal melanomas remain rare. Women were more commonly affected. The most common age group was those older than 65 years, although age did not confer a prognostic value. The most common subsite was the nasal cavity followed by the maxillary sinus. Five-year RS was similar between continents with an inverse relationship between extent of disease and survival. The treatment of choice throughout Europe and the US remains primarily surgical.

Metrics

5 Record Views
8 citations in Web of Science
9 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Otorhinolaryngology
Logo image